Shares in Puma Biotechnology shot up nearly 30 percent on news that the firm’s breast cancer drug is now likely to get a green light from European regulators.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.